Mayne Pharma
Natasha Le is an accomplished finance professional with extensive experience in financial management across various industries. Currently serving as the Head of Finance at Mayne Pharma since May 2020, Natasha leads financial operations for a specialty pharmaceutical company known for its focus on dermatology and women's health. Prior to this role, Natasha held the position of Head of Finance at Toop & Toop Real Estate, a leading real estate agency in Australia, from April 2015 to May 2020. Natasha's background also includes a tenure as a Senior Consultant for Private Clients at PwC Australia, where a diverse range of clients was managed. Early career experiences include roles as a Graduate Accountant at Bray Business Management and as an Accounts Assistant at Mantra Group. Natasha's educational qualifications comprise a Graduate Diploma of Chartered Accounting from the Institute of Chartered Accountants Australia, a Bachelor of Commerce in Accounting from the University of Adelaide, and a Diploma of Business from Eynesbury College.
Mayne Pharma
1 followers
Mayne Pharma Group Ltd is an Australia-based specialty pharmaceutical company. The Company is focused on commercializing branded and generic pharmaceuticals. It operates through four segments: Generic Products (GPD), Specialty Brands (SBD), Metrics Contract Services (MCS) and Mayne Pharma International (MPI). The GPD segment is engaged in the manufacture and distribution of generic pharmaceutical products in the United States. The SBD segment markets and distributes specialty branded pharmaceutical products in the United States. The MCS segment is engaged in the provision of contract analytical and pharmaceutical development services to third-party customers in the United States. The MPI segment is engaged in Australian manufacture and sale of branded and generic pharmaceutical product globally and provision of contract manufacturing services to third-party customers within Australia.